Telitacicept as a novel treatment for refractory lupus nephritis complicated by podocytic infolding glomerulopathy
Rheumatology & Autoimmunity · 2024-09 · 4 (3) · 186-188
DOI: 10.1002/rai2.12130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology & Autoimmunity, online erschienen am 25.04.2024. Verfasst von Lu Zhou und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhou, L., Li, H., Zhang, R., Jiang, Q., & Duan, X. (2024). Telitacicept as a novel treatment for refractory lupus nephritis complicated by podocytic infolding glomerulopathy. Rheumatology & Autoimmunity, 4(3), 186-188. https://doi.org/10.1002/rai2.12130
Vancouver
Zhou L, Li H, Zhang R, Jiang Q, Duan X. Telitacicept as a novel treatment for refractory lupus nephritis complicated by podocytic infolding glomerulopathy. Rheumatology & Autoimmunity. 2024;4(3):186-188. doi:10.1002/rai2.12130
BibTeX
@article{Zhou2024,
author = {Zhou, Lu and Li, Haoguang and Zhang, Rongwei and Jiang, Qifeng and Duan, Xinwang},
title = {Telitacicept as a novel treatment for refractory lupus nephritis complicated by podocytic infolding glomerulopathy},
journal = {Rheumatology & Autoimmunity},
year = {2024},
volume = {4},
number = {3},
pages = {186--188},
doi = {10.1002/rai2.12130}
}
EUVIMED